Endogenous hydrogen sulfide in patients with COPD

Chest

Volumn 128, Issue 5, 2005, Pages 3205-3211

  Chen, Ya Hong ^a   Yao, Wan Zhen ^a   Geng, Bin ^b   Ding, Yan Ling ^a   Lu, Ming ^a   Zhao, Ming Wu ^a   Tang, Chao Shu ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Airway inflammation; Airway obstruction; COPD; Hydrogen sulfide; Nitric oxide

Indexed keywords

CARBON MONOXIDE; HYDROGEN SULFIDE; NITRIC OXIDE;

ADULT; AGE; AIRFLOW; AIRWAY OBSTRUCTION; ARTERIAL GAS; ARTICLE; BLOOD LEVEL; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; SMOKING; SPUTUM;

EID: 28244479039     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3205     Document Type: Article

References (28)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:78-83
2. Barnes PJ. New therapy for chronic obstructive pulmonary disease. Thorax 1998; 53:137-147
3. Hedenstierna G, Hogman M. Can exhaled NO be used as a marker of airway inflammation? Eur Respir J 1998; 12:1248-1249
4. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27:91-97
5. Beauchamp Jr RO, Bus JS, Popp JA, et al. A critical review of the literature on hydrogen sulfide toxicity, C.R.C. Crit Rev Toxicol 1984; 13:25-97
6. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313:362-368
7. Zhang CY, Du JB, Bu DF, et al. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302:810-816
8. 2S be the third endogenous gaseous transmitter? FASEB J 2002; 16:1792-1798
9. Chinese Medical Association. CMA guideline for the management of chronic obstructive pulmonary disease. Chin J Tuber Respir 2002; 25:453-460
10. Pizzichini E, Pizzichini MMM, Elthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317
11. 2S as a novel endogenous gaseous KATP channel opener. EMBO J 2001; 20:6008-6016
12. Gioivannoni G, Land JM, Keir G, et al. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 1997; 34:193-198
13. Fabbri LM, Hurd SS, for the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003; 22:1-2
14. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
15. Corradi M, Majori M, Cacciani GC, et al. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999; 54:572-575
16. Maziak W, Loukides S, Culpitt S, et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:998-1002
17. Ashutosh K, Phadke K, Jackson JF, et al. Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thorax 2000; 55:109-113
18. Eto K, Ogasawara M, Umemura K, et al. Hydrogen sulfide is produced in response to neuronal excitation. J Neurosci 2002; 22:3386-3391
19. Eto K, Asada T, Arima K, et al. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 2002; 293:1485-1488
20. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237:527-531
21. Geng B, Chang L, Pan CS, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318:756-763
22. Du J, Hui Y, Cheung Y, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19:75-80
23. Rutgers SR, van der Mark ThW, Coers W, et al. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 1999; 54:576-580
24. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-271
25. Whiteman M, Cheung NS, Zhu YZ, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 2005; 28, 326:794-798
26. Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"? J Neurochem 2004; 90:765-768
27. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283:H474-H480
28. Zhang QY, Du J, Zhou W, et al. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 2004; 317:30-37